Skip to content

The effect of Thymus Vulgaris inhaling on Chronic Obstructive Pulmonary disease

The effect of Thymus Vulgaris inhaling on respiratory status in patients with exacerbation of Chronic Obstructive Pulmonary disease

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017020732436N1
Enrollment
60
Registered
2017-06-11
Start date
2017-03-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exacerbation Of Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease with acute exacerbation, unspecified

Interventions

Intervention 1: Intervention group: one percent Thymus Vulgaris inhaling will be used as much as 5 ml for the duration of 15 minutes through inhaling treatment mask at the time of patients’ admission
Treatment - Other
Treatment - Drugs
Intervention group: one percent Thymus Vulgaris inhaling will be used as much as 5 ml for the duration of 15 minutes through inhaling treatment mask at the time of patients’ admission who are sufferin
Control group:Distilled water inhaling will be used as much as 5 ml for the duration of 15 minutes with inhaling treatment mask at the time of patients’ admission who are suffering from chronic obstru

Sponsors

Vice Chancellor for Research of Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: No anatomic face problem; Agree to participate in the research; oriented in time, place and person; Age between 50 and 80 years; not being allergic to perfumes and essences. Exclusion criteria: Pregnancy; Nausea and vomiting; Intolerance to the mask used for inhalation therapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Respiratory Rate. Timepoint: Before and after intervention. Method of measurement: Count chest movement during respiration.;Arterial blood oxygen saturation. Timepoint: Before and after intervention. Method of measurement: Finger Pulse Oximeter.;Wheezing. Timepoint: Before and after intervention. Method of measurement: Lung sounds ascultation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElyas Hosseinzadeh Yonesi

Gonabad University of Medical Sciences

e.hosseinzadeh@gmu.ac.ir+98 51 5722 5027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026